Synthace
Engineering Software · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
The Westworks 195 Wood Ln Fl 4, London, ...Phone Number
+44 2039767676Website
www.synthace.comRevenue
<$5 MillionIndustry
About Synthace
Synthace Org Chart
Field Application Scientist II
Is Synthace your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Synthace launches new products
Click to see if Synthace had a recent Job posting/layoffs
Check if Synthace has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Synthace
Synthace, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Synthace has new funding data
Website visits: Recent activity has been detected on your website
Check out if Synthace is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Synthace recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Synthace
Compare insights from companies similar to Synthace, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Synthace is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Synthace is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Synthace.
Synthace financials insights
Gather financial insights about Synthace, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Angel/Seed
$2.1M
Series A
$9.4M
Series B
$25.6M
Series C
$35M
Synthace Tech Stack
A closer look at the technologies used by Synthace
Most Recent Scoops
Synthace News & Media
Synthace's New Report Reveals Challenges and Opportunities in Life Science R&D Experiments
LONDON & BOSTON--(BUSINESS WIRE)-- #Automation--Synthace, the leading digital experiment platform for life science R&D teams, has released a comprehensive analyst report titled Lab automation & experimentation in life science R&D 2023-2024. The report sheds light on the industry challenges faced by researchers and highlights opportunities for improvement. By addressing key themes such as data management, automation hurdles, burdens placed on individual scientists, and lack of support, Synthace aSynthace combines ChatGPT and digital experiments in first step toward a true AI scientist
LONDON & BOSTON--(BUSINESS WIRE)-- #AI--Synthace, creators of the world’s first digital experiment platform for life science R&D, today announces the successful integration of their platform with OpenAI’s ChatGPT. This revolutionary development lets scientists use a natural language interface to describe their intent, use the AI to design complex experiments, and then run those experiments on lab equipment. Watch the video here: https://youtu.be/cdaLgFmqWjU At a glance: what Synthace has done, aSynthace, a Digital Experiment Platform for Life Science R&D, Records Strongest Year Yet
LONDON & BOSTON--(BUSINESS WIRE)-- #Automation--Today, Synthace, a digital life science experiment platform, announces it has had its most successful year on record with major adoption and expansion with customers, industry recognition, product innovation, and a key hire at board level. Major adoption and expansion among the top 100 pharma Synthace experienced 94% annual recurring revenue growth, 166% year-on-year growth in total contract value, and 170% net revenue retention (NRR) growth amongSynthace Appoints Dr. Donald Deieso as New Board Chair
LONDON & BOSTON--(BUSINESS WIRE)-- #AI--Synthace, creators of the world’s first digital life science experiment platform, today announced the appointment of Dr. Donald Deieso as the new Chairman of their Board. Dr. Deieso steps into this role at a time of strong momentum for the company. After closing their Series C funding round last year, Synthace has doubled their year-on-year ARR and expanded to include 8 of the world’s top 12 pharmaceutical companies. “I speak for
Top Engineering Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Synthace
Based in London, UK, and Boston, US, Synthace is accelerating biological discovery and optimisation through computer-aided biology. Their cloud software platform, Antha, empowers biologists by enabling them to flexibly program their lab automation without the need to code. The graphical user interface has been designed by biologists for biologists,... Read More